Filgotinib Clinical Trials
7 recruitingDrug
Phase 33Phase 42Phase 11Phase 21
Showing 1–7 of 7 trials
Recruiting
Phase 3
A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
Ulcerative Colitis
Alfasigma S.p.A.80 enrolled47 locationsNCT06865417
Recruiting
Phase 3
Safety, Tolerability, Pharmacokinetics, and Efficacy of Filgotinib for the Treatment of Polyarticular-course Juvenile Idiopathic Arthritis in Children and Adolescents
Polyarticular Course Juvenile Idiopathic Arthritis
Alfasigma S.p.A.65 enrolled14 locationsNCT07554495
Recruiting
Phase 1
Study to Measure Filgotinib in the Blood of Children and Teenagers With Arthritis Taking Filgotinib (SCALESIA)
Juvenile Idiopathic Arthritis
Alfasigma S.p.A.10 enrolled10 locationsNCT06222034
Recruiting
Phase 2
Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases
Behcet's DiseaseIdiopathic Inflammatory MyopathiesIgG4-related Disease
UMC Utrecht60 enrolled6 locationsNCT06285539
Recruiting
Phase 3
OLE Study With Filgotinib in JIA
Juvenile Idiopathic Arthritis (JIA)
Alfasigma S.p.A.80 enrolled4 locationsNCT07553182
Recruiting
Phase 4
Better After CHoosing. Randomly Allocated or Patient Preference Based Treatment With Filgotinib or TNFi in RA (BACH)
Rheumatoid Arthritis
R.Bos100 enrolled1 locationNCT04985435
Recruiting
Phase 4
Filgotinib Effect on Proteomic Profile and Micro-RNA Expression in Patients With Active Rheumatoid Arthritis (RA)
Rheumatoid Arthritis
Universita di Verona30 enrolled1 locationNCT06527534